ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

SUMMARY

The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market

Founded in 2019 by Shubhendra Singh Thakur and Deovrat Begde, ErlySign develops solutions for early detection of oral cancer

The company also claims to offer India’s first salivary biomarker based test which can identify pre- cancerous conditions

Healthtech startup ErlySign has secured INR 16 Cr (around $1.8 Mn) in Pre-Series A funding round from Ashish Kacholia to further develop its cancer diagnostic solutions. 

The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market, the startup said in its statement. 

“It will support research and development, team expansion, and further patent filings,” it added. The investment was advised by private equity and venture capital advisory firm DerivativeSaint. 

Founded in 2019 by Shubhendra Singh Thakur and Deovrat Begde, ErlySign or CURO Biosciences develops solutions for early detection of oral cancer. 

The company also claims to offer India’s first salivary biomarker based test which can identify pre- cancerous conditions much before visible symptoms emerge. 

The biomarker-based test kit can detect oral precancerous conditions within 15 minutes with a saliva sample to enable timely intervention. 

“The product, now in the final stages of clinical trials across multiple HCG sites, promises to be a game-changer. Beyond early detection, it will serve as a critical screening tool to eliminate unnecessary biopsies and invasive procedures,” said Thakur. 

The development comes at a time when India’s healthcare space is gradually revamping with technological interventions, especially after Covid-19 pandemic. 

According to Inc42’s ‘The State Of Indian Startup Ecosystem Report‘, healthtech startups raised a little over $7 Bn between 2014 and H1 2024 in 886 deals. However, the sector is making progress towards attracting investors’ interest lately and there’s an uptick in funding numbers.

The cumulative funding secured by healthtech startups jumped 2.8X to $460 Mn in the first half (H1) of 2024 from $120 Mn raised in H1 2023. 

Recently, healthtech unicorn Innovaccer raised $275 Mn in its Series F funding round to  transform healthcare with AI and cloud capabilities. 

Last month, healthtech startup Confido Health secured $3 Mn (around INR 25.5 Cr) in its seed funding round led by Together Fund.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.

You have reached your limit of free stories
Become A Startup Insider With Inc42 Plus

Join our exclusive community of 10,000+ founders, investors & operators and stay ahead in india's startup & business economy.

2 YEAR PLAN
₹19999
₹7999
₹333/Month
UNLOCK 60% OFF
Cancel Anytime
1 YEAR PLAN
₹9999
₹4999
₹416/Month
UNLOCK 50% OFF
Cancel Anytime
Already A Member?
Discover Startups & Business Models

Unleash your potential by exploring unlimited articles, trackers, and playbooks. Identify the hottest startup deals, supercharge your innovation projects, and stay updated with expert curation.

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions-Inc42 Media
How-To’s on Starting & Scaling Up

Empower yourself with comprehensive playbooks, expert analysis, and invaluable insights. Learn to validate ideas, acquire customers, secure funding, and navigate the journey to startup success.

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions-Inc42 Media
Identify Trends & New Markets

Access 75+ in-depth reports on frontier industries. Gain exclusive market intelligence, understand market landscapes, and decode emerging trends to make informed decisions.

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions-Inc42 Media
Track & Decode the Investment Landscape

Stay ahead with startup and funding trackers. Analyse investment strategies, profile successful investors, and keep track of upcoming funds, accelerators, and more.

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions-Inc42 Media
ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions-Inc42 Media
You’re in Good company